# Evaluation of Patiromer in Heart Failure Patients

> **NCT00868439** · PHASE2 · COMPLETED · sponsor: **Relypsa, Inc.** · enrollment: 120 (actual)

## Conditions studied

- Hyperkalemia
- Heart Failure

## Interventions

- **DRUG:** patiromer
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00868439
- **Lead sponsor:** Relypsa, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2009-11
- **Final completion:** 2009-12
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2021-06-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00868439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00868439, "Evaluation of Patiromer in Heart Failure Patients". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT00868439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*